Proposed Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research (2020)

A part of PCORI's 2019 reauthorizing law clarifies that PCORI-funded studies should capture "the full range of clinical and patient-centered outcomes," specifically adding "the potential burdens and economic impacts" of healthcare services to the patient-centered outcomes and clinical effectiveness measures that have been the hallmarks of the research we have funded to date.

In September 2020, PCORI’s Board of Governors approved the release of a set of proposed Principles for the Consideration of the Full Range of Outcomes Data for a 60-day public comment period between September 15 and November 13, 2020. In addition to the public comment period, PCORI hosted two webinars and individual stakeholder discussions, which informed the development of the Principles and also highlighted opportunities where PCORI can further advance the implementation of this new legislative authority and support the needs of patients, caregivers, and other stakeholders.

Related Webinars

• Considering the Full Range of Outcomes in PCORI Research – Patients, Caregivers and Consumers
  October 5, 2020
• Considering the Full Range of Outcomes in PCORI Research – Payers, Purchasers, Providers, Health Systems and Pharmaceutical Industry
  October 6, 2020

Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research

In March 2021, PCORI's Board of Governors approved a set of four Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research, which will guide how we implement our expanded authority to consider the potential burdens and economic impacts of healthcare services in the research we fund.

View/Download the Principles

Posted: September 15, 2020; Updated: March 18, 2021